Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the babesia microti-like piroplasm

HIGHLIGHTS

• who: Rocío Checa from the Department of Animal Health, Veterinary Faculty, Universidad Complutense de Madrid, Avenida Puerta de Hierro s/n, Madrid, Spain have published the article: Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm, in the Journal: (JOURNAL)
• what: This study assesses the safety and tolerance of three treatments and compares their efficacy over a full year of follow up in dogs naturally infected with Bml. The sequences obtained during this study were aligned to . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.